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Background: Bacterial meningitis is an infectious disease with high rates of mortality and 
high frequency of severe sequelae. Early identification of causative bacterial and viral 
pathogens is important for prompt and proper treatment of meningitis and for prevention 
of life-threatening clinical outcomes. In the present study, we evaluated the value of the 
Seeplex Meningitis ACE Detection kit (Seegene Inc., Korea), a newly developed multiplex 
PCR kit employing dual priming oligonucleotide methods, for diagnosing acute meningitis. 
Methods: Analytical sensitivity of the kit was studied using reference strains for each patho-
gen targeted by the kit, while it’s analytical specificity was studied using the human ge-
nome DNA and 58 clinically well-identified reference strains. For clinical validation experi-
ment, we used 27 control cerebrospinal fluid (CSF) samples and 78 clinical CSF samples 
collected from patients at the time of diagnosis of acute meningitis. 
Results: The lower detection limits ranged from 10
1 copies/μL to 5×10
1 copies/μL for the 
12 viral and bacterial pathogens targeted. No cross-reaction was observed. In the valida-
tion study, high detection rate of 56.4% was obtained. None of the control samples tested 
positive, i.e., false-positive results were absent. 
Conclusions: The Seeplex Meningitis ACE Detection kit showed high sensitivity, specificity, 
and detection rate for the identification of pathogens in clinical CSF samples. This kit may 
be useful for rapid identification of important acute meningitis-causing pathogens. 
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INTRODUCTION 
Bacterial meningitis is an infectious disease with high rates of 
mortality and severe sequelae. Early identification of causative 
bacterial and viral pathogens is important to enable prompt and 
appropriate treatment and thereby prevent life-threatening clini-
cal outcomes. Patients with suspected meningitis are generally 
prescribed antibiotics before hospital admission or cerebrospi-
nal fluid (CSF) collection for examination. However, the admin-
istration of antibiotics may render it difficult to culture the caus-
ative bacteria, thereby impairing microbiological diagnosis [1, 2]. 
To counter this problem, alternative methods of molecular iden-
tification, including 16S/23S rRNA gene amplification followed 
by sequencing and real-time PCR, have been developed. How-
ever, the clinical application of such techniques is limited be-
cause of the presence of interfering bacterial or viral DNA, time-
consuming nature of these assays, and small number of detec-
tion channels available on the real-time PCR platform [3-7]. Shin SY, et al.
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  These limitations can be overcome by the use of multiplex 
PCR methods, which enable the rapid and accurate identifica-
tion of up to 9 bacterial and viral pathogens in clinical samples 
[8-10]. We evaluated the diagnostic value of the newly devel-
oped Seeplex Meningitis ACE Detection kit (Seegene Inc., Seoul, 
Korea), a multiplex PCR kit that uses dual priming oligonucle-
otide (DPO) methods. This kit detects the 12 most common 
bacterial and viral pathogens of acute meningitis, namely, Strep-
tococcus pneumoniae (SP), Haemophilus influenzae (HI), Neis-
seria meningitidis (NM), Group B streptococci (GBS), Listeria 
monocytogenes (LM), herpes simplex virus (HSV)-1 and HSV-2, 
Varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomega-
lovirus (CMV), human herpes virus 6 (HHV-6), and human en-
terovirus (HEV).
METHODS
1. Seeplex Meningitis ACE Detection kit 
The Seeplex Meningitis ACE Detection kit has 3 components: 
Seeplex Meningitis-B, which detects 5 bacteria (SP, HI type b, 
NM, GBS, and LM); Seeplex Meningitis-V1, which detects 6 vi-
ruses (HSV-1, HSV-2, VZV, EBV, CMV, and HHV-6); and Seeplex 
Meningitis-V2, which detects HEV. The Seeplex Meningitis-B 
and V1 assays amplify DNA, whereas the Seeplex Meningitis-V2 
assay amplifies cDNA reverse-transcribed from viral RNA. The 
target genes amplified from the 12 strains are shown in Table 1. 
2. Multiplex PCR conditions
Each PCR amplification was performed using 5 μL of isolated 
nucleic acid solution, 2 μL of 10×primer mixture, and 10 μL of 2
×Multiplex Master Mix (Seegene Inc.) in a total volume of 20 μL. 
The amplification protocol was as follows: initial denaturation at 
94°C for 15 min, 40 cycles of denaturation at 94°C for 30 sec, 
annealing at 63°C for 90 sec, and extension at 72°C for 90 sec. 
The amplified PCR products were electrophoresed in 2% (w/v) 
agarose gels and stained with ethidium bromide.
3. Analytical sensitivity and specificity of detection 
PCR products were cloned into the vector pUC19 (size, 2,686 
bp). The cloned plasmids were harvested, DNA concentrations 
were measured, and the numbers of target copies were calcu-
lated (1 µg of a 1,000-bp DNA unit equals 9.1×10
11 copies). The 
sensitivity of the system was evaluated by amplifying 10-fold se-
rial dilutions of each plasmid (concentrations, 10
4 to 10
-1 cop-
ies/20 μL), with distilled water as the negative control. Samples 
were PCR-amplified and electrophoresed in 2% (w/v) agarose 
gels. Analytical sensitivity was defined as the lowest template 
copy number for which amplified products were consistently 
Table 1. Target genes used in the Seeplex Meningitis ACE Detection kit 
Organism Target gene Target protein Size of product (bp)
Seeplex  Internal control  1,000
Meningitis-B SP gyrB DNA gyrase, subunit B   669
HI P6 Outer membrane protein (OMP) P6   532
NM ctrA Capsule polysaccharide export outer membrane protein CtrA   410
GBS Cfb CAMP-factor (cfb) gene   315
LM Hly Pore-forming cytolysin listeriolysin   213
Seeplex  Internal control 1,000
Meningitis-V1 CMV UL54 DNA polymerase   590
IE Immediate-early antigen
EBV EBNA1 Epstein-Barr nuclear antigen1   400
HSV-1 UL30 DNA polymerase catalytic subunit   189
HSV-2 gD HSV-2 gD protein   308
VZV ORF66 VZV ORF66 protein   251
HHV-6 U38 DNA polymerase   482
Seeplex  Internal control   850
Meningitis-V2 HEV 5´-UTR 5´-untranslated region   194
Abbreviations: SP, Streptococcus pneumoniae; HI, Haemophilus influenzae; NM, Neisseria meningitidis; GBS, Group B streptococcus; LM, Listeria monocy-
togenes; HSV-1/HSV-2, Herpes simplex virus type 1/2; VZV, Varicella-zoster virus; EBV, Epstein-Barr virus; CMV, Cytomegalovirus; HHV-6, Human herpes vi-
rus 6; HEV, Human enterovirus.Shin SY, et al.
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detected in triplicate samples. The reference strains used for 
the 5 bacteria and 7 viruses were as follows: SP ATCC BAA-
255D, HI ATCC BAA-1416, NM ATCC 700532D, GBS ATCC BAA-
611D, LM ATCC 19114D-5, CMV ATCC VR-807, EBV Korean iso-
late, HSV-1 ATCC VR-260, HSV-2 ATCC VR-734, VZV Korean 
isolate, HHV-6 Korean isolate, and HEV ATCC VR-836/VR-784. 
Primer specificity was assessed by evaluating cross-reactivity 
with human genomic DNA and 58 reference strains, including 
19 HEV species (No.12-30; Table 2).
4. Verification using clinical CSF samples
1) Specimen collection 
Between June and November 2009, 196 clinical CSF samples 
were collected from 78 patients (27 women, 51 men) diagnosed 
with acute meningitis on the basis of clinical symptoms and CSF 
ﬁndings (WBC count, distribution of lymphocytes and neutro-
phils, and glucose level) [11, 12]. Bacterial meningitis was dif-
ferentiated from viral or aseptic meningitis by a WBC count of 
more than 100 cells/mm
3 with neutrophil dominance and a ratio 
of CSF glucose/serum glucose level of less than 0.4. Cases with 
insignificant WBC count or discrepant results in different pa-
rameters were classified into the undetermined group. The me-
dian patient age was 27 yr (range, 1 month to 72 yr). For the 
verification study, we tested only the 78 samples collected at the 
time of diagnosis, i.e., before antibiotic therapy was initiated. 
Another set of 118 samples was used to assess discrepancies in 
positive results obtained from the same patients. Samples that 
were blood-colored, showed leakage, were aged over 12 hr, and 
strongly suspected of being contaminated (with discrepancies 
in the pathogens detected in consecutive tests), were excluded. 
All samples were assessed by conventional CSF microscopic 
analysis, staining, and culture. 
  Control CSF samples were collected from 27 patients; of these 
27 patients, 5 had acute cerebral bleeding; 4, primary or meta-
static brain tumors; 4, tuberculous encephalitis; 2, mumps; and 
1 each, Cryptococcus neoformans infection, clinically suspected 
meningitis due to Candida, and rickettsia. The remaining 9 pa-
tients showed normal findings.
Table 2. Reference strains used for analysis of sensitivity and specificity of the Seeplex Meningitis ACE Detection kit
No. Organism ATCC No. No. Organism ATCC No. No. Organism ATCC No.
0 Human genomic DNA 21 Human echovirus 6 42 N. mucosa 25997
1 S. pneumoniae BAA-255D 22 Human echovirus 7 43 N. sicca 29256
2 H. influenzae BAA-1416 23 Human echovirus 9 44 H. ducreyi 700724D-5
3 N. meningitidis 700532D 24 Human echovirus 11 Korean isolate 45 H. parainfluenzae BAA-730
4 S. agalactiae BAA-611D 25 Human echovirus 25 46 L. ivanovii subsp. ivanovii BAA-678D-5
5 L. monocytogenes 19114D-5 26 Human echovirus 30 47 L. seeligeri 35967D-5
6 CMV VR-807 27 Human poliovirus 3 48 Klebsiella pneumoniae 700721D-5
7 EBV Korean isolate 28 Human echovirus 9 VR-39 49 K. oxytoca 700324D
8 HSV-1 VR-260 29 Human coxsackievirus A24 VR-583 50 Serratia marcescens 14041
9 HSV-2 VR-734 30 Human enterovirus 70 VR-836 51 Enterobacter cloacae 13047D-5
10 VZV Korean isolate 31 S. pyogenes 700294D-5 52 Proteus mirabilis 12453D
11 HHV-6 Korean isolate 32 S. mitis 49456D-5 53 Pseudomonas aeruginosa 47085D
12 Human coxsackievirus A3 VR-1007 33 S. constellatus 27513 54 Acinetobacter baumannii 15308
13 Human enterovirus 71 VR-784 34 S. gordonii 51656 55 Stenotrophomas Maltophilia 13637D-5
14 Human coxsackievirus B1 35 S. oralis 9811 56 S. aureus 700699D-5
15 Human coxsackievirus B2 36 S. salivarius 9759D-5 57 Enterococcus faecium 51559D-5
16 Human coxsackievirus B3 37 S. australis 700641 58 E. faecalis 700802D-5
17 Human coxsackievirus B4 Korean isolate 38 S. ratti 19645
18 Human coxsackievirus B5 39 S. sobrinus 27607
19 Human coxsackievirus B6 40 S. suis BAA-853D
20 Human coxsackievirus A9 41 N. gonorrhoeae 700825D
Abbreviations: CMV, Cytomegalovirus; EBV, Epstein-Barr virus; HSV-1/HSV-2, Herpes simplex virus type 1/2; VZV, Varicella-zoster virus; HHV-6, Human her-
pes virus 6.Shin SY, et al.
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2) DNA and RNA extraction
CSF specimens were centrifuged at 15,000×g for 5 min. DNA 
was extracted from both the supernatant and cell pellet by using 
a nucleic acid purification column according to the manufac-
turer’s instructions (Qiagen Inc., Valencia, CA, USA) and used 
directly for Meningitis-V1 and Meningitis-B1 testing. RNA was 
also extracted from each CSF supernatant. cDNA was synthe-
sized by reverse transcription using RevertAid
TM First Strand 
cDNA Synthesis kits (Fermentas, Ontario, Canada) and used for 
Meningitis-V2 testing. 
3) Sequencing 
Positive results were confirmed by conventional PCR amplifica-
tion by using single primer pairs and subsequent sequencing. 
Amplicons were purified by using a PCR purification kit (Sol-
Gent, Daejeon, Korea) and sequenced by using the BigDye Ter-
minator Cycle Sequencing Kit (PE Applied Biosystems, Foster 
City, CA, USA) and an ABI PRISM 3730XL DNA analyzer (PE 
Applied Biosystems). Sequences were analyzed using the Basic 
Local Alignment Search Tool (BLAST) provided by The National 
Centre for Biotechnology Information (http://www.ncbi.nlm.nih.
gov/BLAST). 
RESULTS
The detection sensitivity was the highest for GBS [lower limit of 
detection (LoD) of 5 genomes/mL] and the lowest for HI (LoD of 
57 genomes/mL). The LoDs for HEV, EBV, VZV, HSV-2, HHV-6, 
NM, CMV, SP, HSV-1, and LM were 10, 11, 11, 12, 12, 13, 16, 
19, 38, and 51 genomes/mL, respectively. The analytical sensi-
tivities for all the 12 target pathogens were higher than the 100 
copies per reaction stated by the manufacturer. No cross-reac-
tion was evident with human genomic DNA and other reference 
strains. The Seeplex Meningitis-V2 ACE Detection kit success-
fully differentiated all the 19 HEV species from the other strains. 
  CSF samples were obtained from 78 patients at the time of 
diagnosis of active meningitis and before administration of anti-
biotic treatment. Among these samples, 44 (56.4%) yielded 
positive results with the Seeplex kit (Table 3). Five cases (6.4%) 
showed positive results for HEV (4) and HSV-1 (1), which were 
consistent with the results of conventional studies. However, in 
2 cases the results were not consistent with the results of con-
ventional studies. One was positive for both LM and EBV in See-
plex Meningitis ACE detection kit, but positive only for LM in the 
conventional study; the other tested positive for HEV in Seeplex 
Meningitis ACE detection kit but positive for VZV in the conven-
tional study. Each case presented a bacterial and a viral fea-
tures, respectively in CSF analysis. 
  The Seeplex Meningitis ACE detection kit detected causative 
pathogens for 37 cases (47.4%) that tested negative in the con-
ventional studies. Two patients had single bacterial infection 
with GBS and LM, and CSF analysis revealed bacterial and un-
determined features, respectively. Single viral infections were 
evident in 16 patients with HEV, 9 with VZV, 3 with HSV-1, and 1 
each with HSV-2 and EBV. All the cases with positive results for 
viruses showed viral or undetermined features in CSF analysis. 
Five patients showed simultaneous infection with 2 bacterial or 
viral pathogens: 2 tested positive for both SP and HEV and 1 
each tested positive for SP and HSV-1, SP and VZV, and EBV 
and HSV-1. One of the cases positive for both SP and HEV had 
Table 3. Distribution of strains detected by Seeplex Meningitis ACE Detection kit and comparison to conventional study results
Seeplex Meningitis 
ACE detection kit 
Positive Negative
Conventional study 
Interpretation
Positive Negative Positive Negative
Concordant Discordant* Bacterial  Viral Co-infection  Bacterial Viral Bacterial Viral Undetermined
N 5 2 2 30 5 1 4 6 13 10
HEV (4) LM/EBV (S), LM (C) (1);  GBS (1) HEV (16) SP + HEV (2) SP (1) EBV (1)
HSV-1 (1) HEV (S), VZV (C) (1) LM (1) VZV (9) SP + HSV-1 (1) VZV (1)
HSV-1 (3) SP + VZV (1) HEV (1)
HSV-2 (1) EBV + HSV-1 (1) HSV-1 (1)
EBV (1)
*Discordant cases consist of a case that was positive for both LM and EBV when tested with the Seeplex Meningitis ACE detection kit (S) but positive for only 
LM in the conventional test (C), and the other case was positive for HEV in Seeplex Meningitis ACE detection kit (S), but positive for VZV in the conventional 
test (C).
Abbreviations: HEV, Human enterovirus; LM, Listeria monocytogenes; EBV, Epstein-Barr virus; GBS, Group B streptococcus; SP, Streptococcus pneumoniae; 
HSV-1, Herpes simplex virus type 1; VZV, Varicella-zoster virus; HSV-2, Herpes simplex virus type 2.Shin SY, et al.
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CSF findings compatible with bacterial meningitis, while the oth-
ers had features consistent of viral meningitis, with lymphocyte 
dominance and high glucose level. Sequencing of amplicons 
showed no evidence of false-positive cross-reactivity; the rates 
of BLAST match were 98-100%. 
  CSF samples obtained from the remaining 34 patients did not 
test positive with the Seeplex kit. Sequential work-up with con-
ventional studies showed that 1 patient each was infected with 
EBV, VZV, SP, HEV, and HSV-1 and had consistent CSF findings. 
The pathogenic agents in the other 29 patients could not be 
identified, although CSF analysis indicated that 6 had bacterial 
infection, 13 had viral infection, and the remaining 10 had inde-
terminate findings. None of the control cases showed false-pos-
itive results. 
DISCUSSION
Acute meningitis requires prompt treatment to avoid life-threat-
ening clinical outcomes and severe sequelae. Since various viral 
and bacterial pathogens can cause acute meningitis, the caus-
ative agent must be identified before treatment is initiated. Con-
ventional diagnostic tools, including CSF staining, culture, and 
antigen analysis, have limited diagnostic sensitivity and specific-
ity. This has prompted the development of several molecular 
methods employing conventional, real-time, or multiplex PCR. 
Although previously developed multiplex PCR methods can rap-
idly identify up to 9 bacterial and viral agents, the Seeplex Menin-
gitis ACE detection kit, which employs a DPO method, can iden-
tify the 12 most common bacterial and viral agents that cause 
meningitis: SP, HI, NM, GBS, LM, CMV, HEV, EBV, HSV-1, HSV-
2, HHV-6, and VZV. DPOs, which consist of 2 separate priming 
regions joined by a polydeoxyinosine linker, yield 2 primer seg-
ments with distinct annealing properties. The long 5′-segment 
initiates stable priming, whereas the short 3′-segment controls 
target-specific extension; the use of these 2 primer segments ef-
fectively eliminates non-specific priming and yields consistently 
high PCR specificity even under less-than-optimal PCR condi-
tions [13]. This method is highly appropriate for the identifica-
tion and differentiation of viral and bacterial pathogens with very 
variable genetic characteristics and low availability of primer 
sites. Several multiplex PCR kits using the DPO technology have 
been developed to identify common viral and bacterial patho-
gens causing respiratory infections and diarrhea, and such kits 
are currently being used in clinical laboratories [14-16]. 
  We found that the Seeplex Meningitis ACE Detection kit of-
fered high sensitivity and specificity for identifying bacterial and 
viral pathogens in patients diagnosed with acute meningitis. The 
LoDs for the 12 pathogens ranged from 10-50 copies/µL, and no 
cross-reaction with human genomic DNA or reference (clinically 
identified) bacterial and viral pathogens was evident, indicating 
the high specificity of the kit. 
  Our validation study revealed that the kit successfully identi-
fied pathogens in the CSF samples collected from 44 of the 78 
(56.4%) patients who were clinically diagnosed with acute men-
ingitis. Only 6 of the 44 pathogens identified using the Seeplex 
Meningitis ACE Detection kit were also identified by other labo-
ratory methods, with the pathogen being HEV in 4 cases and 
HSV-1 and LM in the remaining 2 cases. Six CSF samples were 
simultaneously positive for 2 pathogens, suggesting co-infection 
or contamination rather than false-positivity, because subse-
quent sequencing of PCR products yielded 98-100% matches 
with sequences in the BLAST database. Of the 12 pathogens 
assayed, HEV had the highest prevalence and was detected in 
23 samples by the Seeplex Meningitis ACE Detection kit. Of the 
bacterial strains, SP was the most frequently detected; SP was 
detected in 5 samples, although it was detected along with vi-
ruses, including HEV, HSV-1, and VZV, in 4 samples. 
  Five of the 34 patients, whose samples were negative at the 
time of diagnosis were later found to have EBV, VZV, SP, HEV, 
and HSV-1 infection when investigated by conventional studies. 
These discrepancies were perhaps attributable to inter-speci-
men differences at varying stages of infection. Of the other 29 
patients who tested negative for all pathogens, 10 had indeter-
minate CSF parameters, whereas 19 showed findings consistent 
with bacterial or viral infection. The presence of clinical features 
of meningitis and indeterminate CSF findings in the 10 patients 
may be attributed to conditions other than acute viral or bacte-
rial meningitis. In contrast, meningitis in the 19 patients with 
CSF findings consistent with bacterial or viral infections may 
have been caused by pathogens other than the 12 assayed by 
the Seeplex Meningitis ACE Detection kit. Alternatively, the con-
centration of pathogens in the CSF may have been too low to 
permit detection. 
  In conclusion, the Seeplex Meningitis ACE Detection kit show-
ed high sensitivity and specificity for the 12 most common bac-
terial and viral agents causing acute meningitis. A high detection 
rate was observed in the CSF samples obtained from patients 
clinically diagnosed with acute meningitis. This kit may enable 
the rapid identification of pathogens in patients with acute men-
ingitis.Shin SY, et al.
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